Abbott’s Spinal Cord Stimulation Systems Demonstrate Long-Term Efficacy in Chronic Pain Management
FDA Approval:
Abbott received FDA approval for its spinal cord stimulation (SCS) systems to treat chronic back pain in people who have limited surgical options12.
BurstDR Technology:
Abbott's proprietary BurstDR stimulation technology mimics natural brain patterns to deliver superior pain relief compared to traditional tonic stimulation24.
DISTINCT Study:
The FDA approval was supported by Abbott's DISTINCT study, the largest randomized controlled trial for SCS in people with chronic back pain when surgery is not an option2.
Pain Relief Efficacy:
85.2% of patients implanted with Abbott's SCS system achieved significant back pain reduction, compared to only 7.1% for conventional medical management3.
Multiple Pain Areas:
The Proclaim Plus SCS system features FlexBurst360 therapy, which offers pain coverage across up to six areas of the trunk and/or limbs4.
Long-Term Battery Life:
Abbott's recharge-free SCS systems can last up to 10 years at low-dose settings, providing hassle-free pain relief5.
Patient Preference:
Patient preference for Abbott's BurstDR system grew over time, with 81% of patients choosing it at two years compared to 68% at 12 months6.
Comprehensive Portfolio:
Abbott offers a range of neuromodulation therapies for chronic pain and movement disorders, including SCS, dorsal root ganglion (DRG) stimulation, and deep brain stimulation (DBS)710.
Remote Programming:
Abbott's SCS systems are compatible with NeuroSphere Virtual Clinic, allowing patients to receive remote programming adjustments from home47.
Indications:
Abbott's SCS systems are indicated for managing chronic, intractable pain of the trunk and/or limbs, including failed back surgery syndrome, non-surgical back pain, and diabetic peripheral neuropathy9.
Sources:
1. https://www.fda.gov/medical-devices/recently-approved-devices/abbott-spinal-cord-stimulation-scs-systems-p010032s191
2. https://www.prnewswire.com/news-releases/abbott-receives-fda-approval-for-its-spinal-cord-stimulation-systems-to-treat-chronic-back-pain-in-people-who-have-limited-surgical-options-301825846.html
3. https://www.neuromodulation.abbott/us/en/healthcare-professionals/hcp-chronic-pain/scs-nsbp.html
4. https://www.prnewswire.com/news-releases/fda-approves-abbotts-new-spinal-cord-stimulation-device-provides-tailored-relief-to-multiple-pain-areas-and-adds-more-treatment-options-for-evolving-pain-conditions-301610549.html
5. https://www.neuromodulation.abbott/us/en/chronic-pain/how-neurostimulation-treats/proclaim-xr-scs-system.html
6. https://www.massdevice.com/abbott-nevro-tout-spinal-cord-stimulation-tech/
7. https://www.abbott.com/for-healthcare-professionals/neuromodulation.html
9. https://www.neuromodulation.abbott/us/en/chronic-pain/pain-relief/try-neurostimulator-first.html